Emeis share breaks below its 11.94 € support level and extends its decline
The medicalised accommodation and care group is losing ground this Thursday afternoon, crossing downward a technical threshold monitored over several sessions. The momentum remains deteriorated across all short-term horizons, in a European market itself slightly in the red.
An 11.94 € support broken during the session, within a persistent downtrend context
The Emeis share is declining by 2.74% to 11.72 € during this Thursday's session, after breaking through its 11.94 € support level downward. The stock remains below this threshold, confirming the fragility of the chart configuration. Over one month, the decline reaches 16.17%, and over one week, the stock is down a further 5.48%, making it one of the steepest declines of this period.
Three moving averages are weighing well above the price: the 20-day MA at 12.60 € (a gap of nearly 7%), the 50-day MA at 13.49 € (a gap of more than 13%) and the 200-day MA at 13.98 € (a gap of more than 16%), with the stock trading below all three levels. The RSI at 33 is approaching the oversold zone without yet reaching it outright, reflecting the progressive exhaustion of selling pressure at these levels. The nearest resistance, at 14.45 €, remains very far from the current price.
First-half results revised upward but a stock market dynamic that is not following suit
Upon publication of the first half of 2026 (on July 29, 2026), the group had raised its annual guidance, indicating that first-half performance "allowed for an upward revision of 2026 objectives" and even showed "results exceeding initial expectations". This confident tone contrasts with the stock decline accumulated since last summer. The stock had touched a low point at 11.78 € on September 21, before a rebound that failed to hold in the following sessions.
In a difficult market context for risk assets, the SBF 120 is down 0.26% during the session, as rising bond yields weigh on stock valuations across Europe. The next technical landmark to watch remains the lower boundary around 11.78 €, already tested last week.